Optimum News 12 Newsday.com MSG Varsity Explore LI AM New York Optimum Autos Optimum Homes
Print Aa
From

FDA OKs Drug for Advanced Prostate Cancer

Published: August 31, 2012 4:51 PM
 -- Margaret Steele

Photos

A new drug designed to treat advanced prostate cancer that isn't responding to other therapies received U.S. Food and Drug Administration approval Friday.

The drug, to be sold as Xtandi (enzalutamide), received expedited approval under FDA's priority review program for medicines that have the potential to significantly advance current treatment, the agency said.

"The need for additional...

Content Preview This content is exclusive for Newsday digital access and 7-day home delivery subscribers and Optimum Online customers.

Already
registered?
Log in
Already a
subscriber/customer?
Register
Get a 4-week trial for $1
Subscribe

advertisement | advertise on newsday

Newsday features

Facebook

advertisement | advertise on newsday

Top Jobs